CytomX Therapeutics (CTMX) Short Interest Ratio & Short Volume → Your Money is Not Safe (From American Alternative) (Ad) Free CTMX Stock Alerts $1.67 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CytomX Therapeutics Short Interest DataCurrent Short Volume3,320,000 sharesPrevious Short Volume3,530,000 sharesChange Vs. Previous Month-5.95%Dollar Volume Sold Short$7.24 millionShort Interest Ratio / Days to Cover3.8Last Record DateMarch 31, 2024Outstanding Shares67,730,000 sharesPercentage of Shares Shorted4.90%Today's Trading Volume257,894 sharesAverage Trading Volume847,565 sharesToday's Volume Vs. Average30% Short Selling CytomX Therapeutics ? Sign up to receive the latest short interest report for CytomX Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTMX Short Interest Over TimeCTMX Days to Cover Over TimeCTMX Percentage of Float Shorted Over Time Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW CytomX Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20243,320,000 shares $7.24 million -6.0%N/A3.8 $2.18 3/15/20243,530,000 shares $7.31 million +115.2%N/A4.1 $2.07 2/29/20241,640,000 shares $4.02 million +26.2%N/A2.2 $2.45 2/15/20241,300,000 shares $1.95 million +4.0%N/A2.8 $1.50 1/31/20241,250,000 shares $1.91 million -5.3%N/A4.2 $1.53 1/15/20241,320,000 shares $2.28 million -0.8%N/A4.4 $1.73 Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,330,000 shares $2.06 million +35.5%N/A4.9 $1.55 12/15/2023981,600 shares $1.38 million -26.8%N/A5 $1.41 11/30/20231,340,000 shares $1.86 million +0.8%N/A7.5 $1.39 11/15/20231,330,000 shares $1.72 million +5.6%N/A8 $1.29 10/31/20231,260,000 shares $1.39 million -18.2%N/A7 $1.10 10/15/20231,540,000 shares $1.93 million -9.9%N/A8.5 $1.25 9/30/20231,710,000 shares $2.21 million -23.0%N/A9.5 $1.29 9/15/20232,220,000 shares $3.06 million +2.3%N/A8.2 $1.38 8/31/20232,170,000 shares $3.26 million +5.9%N/A7.5 $1.50 8/15/20232,050,000 shares $3.26 million -21.5%N/A6.5 $1.59 7/31/20232,610,000 shares $4.54 million -3.0%4.0%7 $1.74 7/15/20232,690,000 shares $4.90 million +13.0%4.1%6.8 $1.82 6/30/20232,380,000 shares $4.09 million No Change3.7%5.3 $1.72 6/15/20232,380,000 shares $3.71 million +4.4%3.7%4.5 $1.56 5/31/20232,280,000 shares $3.90 million +7.0%3.5%3.4 $1.71 5/15/20232,130,000 shares $3.88 million -13.4%3.3%2.8 $1.82 4/30/20232,460,000 shares $4.01 million +9.3%3.8%2.8 $1.63 4/15/20232,250,000 shares $3.74 million +40.6%3.5%2 $1.66 3/31/20231,600,000 shares $2.42 million -14.9%2.5%1 $1.51 3/15/20231,880,000 shares $3.82 million +48.0%2.9%0.8 $2.03 2/28/20231,270,000 shares $2.73 million -8.0%2.0%0.5 $2.15 2/15/20231,380,000 shares $3.20 million -13.8%2.1%0.5 $2.32 1/31/20231,600,000 shares $4.32 million -43.3%2.5%0.5 $2.70 1/15/20232,820,000 shares $8.07 million +433.7%4.3%1 $2.86 12/30/2022528,400 shares $845,440.00 -64.1%0.8%0.2 $1.60 12/15/20221,470,000 shares $2.34 million -26.1%2.3%1.1 $1.59 11/30/20221,990,000 shares $3.46 million +103.7%3.1%1.6 $1.74 11/15/2022977,100 shares $1.16 million -2.0%1.5%0.8 $1.19 10/31/2022997,400 shares $1.31 million -6.8%1.6%2 $1.31 10/15/20221,070,000 shares $1.52 million -10.8%1.7%1.6 $1.42 9/30/20221,200,000 shares $1.74 million +2.6%1.9%1.3 $1.45 9/15/20221,170,000 shares $1.94 million +30.9%1.9%0.7 $1.66 8/31/2022894,100 shares $1.34 million -14.0%1.4%0.5 $1.50 8/15/20221,040,000 shares $1.80 million -21.2%1.7%0.6 $1.73Your Money is Not Safe (Ad)Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW CTMX Short Interest - Frequently Asked Questions What is CytomX Therapeutics' current short interest? Short interest is the volume of CytomX Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 3,320,000 shares of CTMX short. Learn More on CytomX Therapeutics' current short interest. What is a good short interest ratio for CytomX Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTMX shares currently have a short interest ratio of 4.0. Learn More on CytomX Therapeutics's short interest ratio. Is CytomX Therapeutics' short interest increasing or decreasing? CytomX Therapeutics saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 3,320,000 shares, a drop of 5.9% from the previous total of 3,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytomX Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to CytomX Therapeutics: Vistagen Therapeutics, Inc. (5.27%), Eliem Therapeutics, Inc. (0.07%), Karyopharm Therapeutics Inc. (19.94%), Nuvectis Pharma, Inc. (12.12%), Repare Therapeutics Inc. (2.39%), FibroGen, Inc. (5.65%), OptiNose, Inc. (2.76%), Citius Pharmaceuticals, Inc. (7.81%), Coya Therapeutics, Inc. (1.53%), Sagimet Biosciences Inc. (19.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short CytomX Therapeutics stock? Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytomX Therapeutics? A short squeeze for CytomX Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTMX, which in turn drives the price of the stock up even further. How often is CytomX Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTMX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: VTGN Short Interest ELYM Short Interest KPTI Short Interest NVCT Short Interest RPTX Short Interest FGEN Short Interest OPTN Short Interest CTXR Short Interest COYA Short Interest SGMT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTMX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press